Benzene and multiple myeloma: Appraisal of the scientific evidence

Blood

Volumn 94, Issue 4, 1999, Pages 1174-1182

  Bergsagel, Daniel E ^a   Wong, Otto ^b   Bergsagel, P Leif ^b   Alexanian, Raymond ^b   Anderson, Kenneth ^b   Kyle, Robert A ^b   Raabe, Gerhard K ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CARCINOGEN;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; HUMAN; MULTIPLE MYELOMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW;

AIR POLLUTANTS, OCCUPATIONAL; BENZENE; CARCINOGENS; ENVIRONMENTAL EXPOSURE; HUMANS; MULTIPLE MYELOMA; RISK FACTORS;

EID: 0033566886     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Aksoy M, Dinçol K, Erdem S, Akgun T, Dinçol G: Details of blood changes in 32 patients with pancytopenia associated with long-term exposure to benzene. Br J Ind Med 29:56, 1972
2. Vigliani EC, Forni A: Benzene and leukemia. Environ Res 11:122, 1976
3. Torres A, Giralt M, Raichs A: Coexistencia de antecedentes benzólicos crónicosy plasmocitoma multiple. Presentación de dos casos. Sangre 15:275, 1970
4. Aksoy M, Erdem S, Dinçol G, Kutlar A, Bakioglu I, Hepyüksel T: Clinical observations showing the role of some factors in the etiology of multiple myeloma. Acta Haematol 71:116, 1984
5. Hill AB: The environment and disease: Association or causation? Proc R Soc Med 58:295, 1965
6. Hill AB: Principles of Medical Statistics (ed 9). New York, NY, Oxford, 1971
7. Axelsson U, Bachmann R, Hällén J: Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand 179:235, 1966
8. Bladé J, Kyle RA: Monoclonal gammopathies of undetermined significance, in Malpas JS, Bergsagel DE, Kyle R, Anderson K (eds): Myeloma: Biology and Management (ed 2). Oxford, UK, Oxford, 1998, p 513
9. Gabrea A, Bergsagel PL, Chesi M, Shou Y, Kuehl WM: Insertion of IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Mol Cell 3:119, 1999
10. Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL: The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92:3025, 1998
11. Sawyer JR, Lukacs JL, Munshi N, Desikan KR, Singhal S, Mehta J, Siegel D, Shaughnessy J, Barlogie B: Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood 92:4269, 1998
12. Avet-Loiseau H, Li JY, Facon T, Brigaudeau C, Morineau N, Maloisel F, Rapp MJ, Talmant P, Trimoreau F, Jaccard A, Harousseau JL, Bataille R: High incidence of translocations t(11;14)(q13;q32) and in patients with plasma cell malignancies. Cancer Res 58:5640, 1998
13. Solly S: Remarks on the pathology of mollities ossium with cases. Medico-Chirurgical Transactions London 24:435, 1844
14. Blattner WA: Epidemiology of multiple myeloma and related plasma cell disorders, in PotterM(ed): Progress in Myeloma, Biology of Myeloma. New York, NY, Elsevier/North Holland, 1980, p 1
15. Reis LAG, Miller BA, Hankey BF, Kosary BL, Harras A, Edwards BK: SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. National Cancer Institute Publication No 94-2789. Washington, DC, US Government Printing Office, 1994
16. Riedel DA, Pottern LM, Blattner WA: Epidemiology of multiple myeloma, in Wiernik PH, Canellos GP, Kyle RA, Schiffer CA (eds): Neoplastic Diseases of the Blood, vol 1 (ed 2). New York, NY, Churchill Livingston, 1991, p 347
17. Hjorth M, Holmberg E, Rödjer S, Westin J: Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. The Myeloma Group of Western Sweden. Br J Haematol 80:55, 1992
18. Maldonado JE, Kyle RA: Familial myeloma: Report of eight families and a study of serum proteins in their relatives. Am J Med 57:875, 1974
19. Zawadzki ZA, Aizawa Y, Kraj MA, Haradin AR, Fisher B: Familial immunopathies: Report of nine families and survey of literature. Cancer 40:2094, 1977
20. Grosbois F, Gueguen M, Fauchet R, Lebouc H, Guenot A, Lancelin F, Lauvin R, Leblay R, Genetet B: Multiple myeloma in two brothers. An immunochemical and immunogenetic familial study. Cancer 58:2417, 1986
21. Bizzaro N, Pasini P: Familial occurrence of multiple myeloma and monoclonal gammopathy of undetermined significance in 5 siblings. Haematologica 75:58, 1990
22. Loth TS, Perrotta AL, Lima J, Whiteaker RS, Robinson A: Genetic aspects of familial multiple myeloma. Mil Med 156:430, 1991
23. Crozes Bony P, Palazzo E, Meyer O, Debandt M, Kahn MF: Familial multiple myeloma - Report of a case in a father and daughter - Review of the literature. Rev Du Rhumatisme 62:439, 1995
24. Herrinton LJ, Weiss NS, Olshan AF: Epidemiology of myeloma, in Malpas JS, Bergsagel DE, Kyle R, Anderson K (eds): Myeloma: Biology and Management (ed 2). Oxford, UK, Oxford, 1998, p 150
25. Riedel DA, Pottern LM: The epidemiology of multiple myeloma. Hematol Oncol Clin N Am 6:225, 1992
26. Wallace LA: Environmental exposure to benzene: An update. International Conference on the Toxicity, Carcinogenesis and Epidemiology of Benzene, 17 June, 1995, Rutgers University. Environ Health Persp 104:1129, 1996
27. IARC: International Agency for Research on Cancer (IARC) monographs on the evaluation of carcinogenic risks in humans. Some industrial Chemicals and Dyestuffs, vol 29. Lyon, France, World Health Organization, 1982
28. Snyder R, Wix G, Goldstein BD: The toxicology of benzene. Environ Health Persp 100:295, 1993
29. Forni A, Pacifico E, Limonta A: Chromosome abnormalities in workers exposed to benzene or toluene or both. Arch Environ Health 22:373, 1971
30. Forni A, Cappellini A, Pacifico E, Virgilani E: Chromosome changes and their evolution with past exposure to benzene. Arch Environ Health 23:385, 1971
31. Hite M, Pecharo M, Smith I, Thornton S: The effect of benzene in the micronucleus test. Mutat Res 77:149, 1980
32. Tice RR, Costa DL, Drew RT: Cytogenetic effects of inhaled benzene in murine bone marrow: Induction of sister chromosome exchanges, chromosomal aberrations, and cellular proliferation inhibition in DBA/2 mice. Proc Natl Acad Sci USA 77:2148, 1980
33. Tice RR, Vogt TF, Costa DL: Cytogenetic effects of inhaled benzene in murine bone marrow in genotoxic effect of airborne agents. Environ Sci Res 25:257, 1982
34. Aksoy M, Erdem S: Followup study on the mortality and the development of leukemia in 44 pancytopenic patients with chronic exposure to benzene. Blood 52:285, 1978
35. ATSDR: Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Benzene. Bethesda, MD, US Department of Health and Human Services, 1995
36. Aksoy M, Erdem S, Dinçol G: Leukemia in shoe-workers exposed chronically to benzene. Blood 44:837, 1974
37. Wong O: An industry wide mortality study of chemical workers occupationally exposed to benzene. I. General results. Br J Ind Med 44:365, 1987
38. Wong O: An industry wide mortality study of chemical workers occupationally exposed to benzene. II. Dose response analyses. Br J Ind Med 44:382, 1987
39. Mrozek K, Heinonen K, de la Chapelle A, Bloomfield CD: Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 24:17, 1997
40. Stanulla M, Wang J, Chervinsky DS, Aplan PD: Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus. Leukemia 11:490, 1997
41. Aplan PD, Chervinsky DS, Stanulla M, Burhans WC: Site-specific DNA cleavage within the MLL breakpointcluster region induced by topoisomerase II inhibitors. Blood 87:2649, 1996
42. Broeker PL, Super HG, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S, Zeleznik-Le N, Rowley JD: Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87:1912, 1996
43. General S: Smoking and Health. Washington, DC, US Government Printing Office, 1964
44. IARC: International Agency for Research in Cancer (IARC) Monographs on the Evaluation of Carcinogenic Risks to Humans. Occupational Exposures in Petroleum Refining; Crude Oil and Major Petroleum Fuels, vol 45. Lyon, France, World Health Organization, 1989
45. Aksoy M: Malignancies due to occupational exposure to benzene. Am J Ind Med 7:395, 1985
46. Infante PF, Rinsky RA, Wagoner JK, Young RJ: Leukaemia in benzene workers. Lancet 2:76, 1977
47. Rinsky RA, Young RJ, Smith AB: Leukemia in benzene workers. Am J Ind Med 2:217, 1981
48. Rinsky RA, Smith AB, Hornung R, Fillon TG, Young RJ, Okun AH, Landrigan PJ: Benzene and leukemia: An epidemiologic risk assessment. N Engl J Med 316:1044, 1987
49. Paxton MB, Chinchilli VM, Brett SM, Rodricks JV: Leukemia risk associated with benzene exposure in the pliofilm cohort: I. Mortality update and exposure distribution. Risk Anal 14:147, 1994
50. Paxton MB, Chinchilli VM, Brett SM, Rodricks JV: Leukemia risk associated with benzene exposure in the pliofilm cohort. II. Risk estimates. Risk Anal 14:155, 1994
51. Wong O: Risk of myelogenous leukemia and multiple-myeloma in workers exposed to benzene - Reply. Occup Environ Med 53:357, 1996
52. Wong O: Risk of acute myeloid leukemia and multiple myeloma in workers exposed to benzene. Occup Environ Med 52:380, 1995
53. Brandt L, Nilsson PG, Mitelman F: Occupational exposure to petroleum products in men with acute non-lymphocytic leukemia. Br J Med 1:553, 1978
54. Malone KE, Koepsell TD, Daling JR, Weiss NS, Morris PD, Taylor JW, Swanson GM, Lyon LY: Chronic lymphocytic leukemia in relation to chemical exposures. Am J Epidemiol 130:1152, 1989
55. Linet MS, Malker HSR, McLaughlin JK, Weiner JA, Stone BJ, Blot WJ, Ericsson JLE, Fraumeni JF: Occupation and leukemia: Response to Dr. William E. Morton (letter to the editor). Am J Ind Med 15:609, 1989
56. Satin KP, Wong O, Yuan LA, Bailey WJ, Newton KL, Wen CP, Swencicki RE: A 50-year mortality follow-up of a large cohort of oil refinery workers in Texas. J Occup Environ Med 38:492, 1996
57. Collingwood KW, Raabe GK, Wong O: An updated cohort mortality study of workers at a northeastern United States petroleum refinery. Int Arch Occupational Environ Health 68:277, 1996
58. Raabe GK, Collingwood KW, Wong O: An updated mortality study of petroleum workers in Beaumont, Texas. Am J Ind Med 33:61, 1998
59. Crump KS, Allen BC: Quantitative Estimates of Risk of Leukemia From Occupational Exposure to Benzene. Technical Report to the Occupational Safety and Health Administration. Washington, DC, 1984
60. Paustenbach DJ, Price PS, Ollison W, Blank C, Jernigan JD, Bass RD, Peterson HD: Reevaluation of benzene exposure in the Pliofilm (rubberworks) cohort (1936-1976). Toxicol Environ Health 36:177, 1992
61. Irons RD, Stillman WS, Colagniovanni DB, Henry VAS: Synergistic action of the benzene metabolite, hydroquinone, on myelopoietic stimulation activity of granulocytic macrophage colony stimulating factor in vitro. Proc Natl Acad Sci USA 89:3691, 1992
62. Hazel BA, O'Connor A, Nicolescu R, Kolf GF: Benzene and its metabolite, hydoquinone, induce granulocytic differentiation in myeloblasts by interacting with cellular signaling pathways activated by granulocyte colony-stimulating factor. Stem Cells 13:295, 1995
63. Bond GG, McLaren EA, Baldwin CL, Cook RR: An update of mortality of chemical workers exposed to benzene. Br J Ind Med 43:685, 1986
64. Decouflé P, Blattner WA, Blair A: Mortality among chemical workers exposed to benzene and other agents. Environ Res 30:15, 1983
65. Paci E, Buiatti E, Costantini AS, Miligi L, Pucci N, Scarpelli A, Petrioli G, Simonato L, Winkelmann R, Kaldo J: Aplastic anemia, leukemia and other cancer mortalityin a cohort of shoe workers exposed to benzene. Scand J Work Environ Health 15:313, 1989
66. Yin SN, Hayes RB, Linet MS, Li GL, Dosemeci M, Travis LB, Li CY, Zhang ZN, Li DG, Chow WH, Wacholder S, Wan YZ, Jiang ZL, Dai R, Zhang WI, Chao XJ, Ye PC, Kou QR, Zhang XC, Lin XF, Meng JF, Ding CY, Zho JS, Blot WJ: A cohort study of cancer among benzene-exposed workers in China: Overall results. Am J Ind Med 29:227, 1996
67. Smith TJ, Hammond SK, Hallock M, Wong O: Health effects of gasoline exposure. I: Exposure patterns of distribution workers in the United States. Environ Health Persp 101:13, 1993
68. Wong O, Harris F, Smith TJ: Health effects of gasoline exposure. II: Mortality patterns of distribution workers in the United States. Environ Health Persp 101:63, 1993
69. Wong, Trent L, Harris F: Nested case-control study of leukemia, multiple myeloma and kidney cancer in a cohort of petroleum workers exposed to gasoline. Occup Environ Med 56:217, 1999
70. Schnatter AR, Armstrong TW, Nicolich MJ, Thompson FS, Katz AM, Huebner WW, Pearlman ED: Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occupational Environ Med 53:773, 1996
71. Lynge E, Anderson A, Nilsson R, Barlow L, Pukkala E, Nordlinder R, Boffetta P, Grandjean P, Heikkila P, Hörte J, Jacobsson RLI, Moen B, Rilse T: Risk of cancer and exposure to gasoline vapors. Am J Epidemiol 145:449, 1997
72. Wong O, Raabe GK: Multiple myeloma and benzene exposure in a multi-national cohort of more than 250,000 petroleum workers. Regul Toxicol Pharmacol 26:188, 1997
73. Wong O, Raabe GK: Cell-type specific leukemia analyses in a combined cohort of more than 208,000 petroleum workers in the United States and the United Kingdom, 1937-1989. Regul Toxicol Pharmacol 21:307, 1995
74. Wong O, Raabe GK: The application of meta-analysis in reviewing occupational cohort studies. Occup Environ Med 53:793, 1996
75. Linet MS, Harlow SD, McLaughlin JK: A case-control study of multiple myeloma in whites: Chronic antigenic stimulation, occupation and drug use. Cancer Res 47:2978, 1987
76. Morris PD, Koepsell TD, Daling JR, Taylor JW, Lyon JL, Swanson GM, Child M, Weiss NS: Toxic substance exposure and multiple myeloma: A case-control study. J Natl Cancer Inst 76:987, 1986
77. Flodin U, Fredriksson M, Persson B: Multiple myeloma and engine exhausts, fresh wood and creosote: A case-referent study. Am J Ind Med 12:519, 1987
78. Eriksson M, Karlsson M: Occupational and other environmental factors and multiple myeloma: A population based case-control study. Br J Ind Med 49:95, 1992
79. Heineman EF, Olsen JH, Pottern LM, Gomez M, Raffn E, Blair A: Occupational risk factors for multiple myeloma among Danish men. Cancer Causes Control 3:555, 1992
80. Pottern LM, Heineman EF, Olsen JH, Raffn E, Blair A: Multiple myeloma among Danish women: Employment history and workplace exposures. Cancer Causes Control 3:427, 1992
81. Cuzick J, De Stavola B: Multiple myeloma - A case-control study. Br J Cancer 57:516, 1988